Gladius Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,492	Closed	-$18.3K	–	308
2023 Q2	$18.3K	Sell	2,492 -217	-8%	-$1.6K	﹤0.01%	222
2023 Q1	$28.1K	Sell	2,709 -404	-13%	-$4.19K	﹤0.01%	216
2022 Q4	$36.8K	Buy	3,113 +1,531	+97%	+$18.1K	﹤0.01%	199
2022 Q3	$34K	Buy	+1,582	New	+$34K	﹤0.01%	209